Vepoloxamer

DRUG2 trials

Sponsors

Mast Therapeutics, Inc.

Conditions

Chronic Heart FailureHealthy VolunteersPharmacokinetics of VepoloxamerRenal Impaired

Phase 1

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

CompletedNCT02646358

Mast Therapeutics, Inc.Healthy Volunteers, Pharmacokinetics of Vepoloxamer, Renal Impaired

Start: 2016-01-31Updated: 2016-12-22

Phase 2

Evaluation of Vepoloxamer in Chronic Heart Failure

TerminatedNCT02596477

Mast Therapeutics, Inc.Chronic Heart Failure

Start: 2015-10-31Updated: 2016-10-28